

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.24697619 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.24697619 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.03338916 |
| 4 | * positive regulation of gamma-delta T cell activation (GO:0046645) | 5.04197802 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.84354958 |
| 6 | NIK/NF-kappaB signaling (GO:0038061) | 4.62615229 |
| 7 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.57708245 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.28610572 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.28610572 |
| 10 | * positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.15354169 |
| 11 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12591466 |
| 12 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12591466 |
| 13 | modulation by symbiont of host immune response (GO:0052553) | 4.12591466 |
| 14 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12591466 |
| 15 | modulation by symbiont of host defense response (GO:0052031) | 4.12591466 |
| 16 | * positive regulation of natural killer cell differentiation (GO:0032825) | 3.90842867 |
| 17 | * negative regulation of erythrocyte differentiation (GO:0045647) | 3.86713650 |
| 18 | myeloid dendritic cell differentiation (GO:0043011) | 3.85423547 |
| 19 | * regulation of gamma-delta T cell differentiation (GO:0045586) | 3.79931928 |
| 20 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.77545252 |
| 21 | * regulation of gamma-delta T cell activation (GO:0046643) | 3.77037997 |
| 22 | myeloid dendritic cell activation (GO:0001773) | 3.74419316 |
| 23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.72907431 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.71010964 |
| 25 | negative T cell selection (GO:0043383) | 3.65768202 |
| 26 | negative thymic T cell selection (GO:0045060) | 3.62790505 |
| 27 | response to type I interferon (GO:0034340) | 3.61873973 |
| 28 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60215878 |
| 29 | type I interferon signaling pathway (GO:0060337) | 3.59091025 |
| 30 | cellular response to type I interferon (GO:0071357) | 3.59091025 |
| 31 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.56876090 |
| 32 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.53751876 |
| 33 | negative regulation of T cell mediated immunity (GO:0002710) | 3.49865826 |
| 34 | detection of other organism (GO:0098543) | 3.44704592 |
| 35 | response to interleukin-15 (GO:0070672) | 3.43661494 |
| 36 | positive regulation of humoral immune response (GO:0002922) | 3.43578270 |
| 37 | detection of bacterium (GO:0016045) | 3.37161174 |
| 38 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.35533869 |
| 39 | * JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.34025031 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29375503 |
| 41 | defense response to protozoan (GO:0042832) | 3.29113443 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.28119163 |
| 43 | * positive regulation of interleukin-2 production (GO:0032743) | 3.25679326 |
| 44 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.23747632 |
| 45 | positive regulation of interferon-alpha production (GO:0032727) | 3.23531995 |
| 46 | response to protozoan (GO:0001562) | 3.22983433 |
| 47 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.19190737 |
| 48 | positive regulation of isotype switching (GO:0045830) | 3.18694427 |
| 49 | immunoglobulin mediated immune response (GO:0016064) | 3.18184202 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.15284325 |
| 51 | B cell mediated immunity (GO:0019724) | 3.14720526 |
| 52 | positive regulation of interleukin-17 production (GO:0032740) | 3.14678976 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.14389066 |
| 54 | regulation of T-helper cell differentiation (GO:0045622) | 3.13535252 |
| 55 | regulation of RIG-I signaling pathway (GO:0039535) | 3.12587449 |
| 56 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.12307108 |
| 57 | positive thymic T cell selection (GO:0045059) | 3.10562147 |
| 58 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09067409 |
| 59 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.08449863 |
| 60 | * regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.08349613 |
| 61 | positive regulation of antigen processing and presentation (GO:0002579) | 3.08203780 |
| 62 | regulation of interferon-alpha production (GO:0032647) | 3.07232817 |
| 63 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.06816090 |
| 64 | positive regulation of B cell mediated immunity (GO:0002714) | 3.06816090 |
| 65 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.05346913 |
| 66 | positive regulation of interleukin-12 production (GO:0032735) | 3.05026858 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.00841880 |
| 68 | response to host immune response (GO:0052572) | 2.96722151 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.96722151 |
| 70 | neutrophil activation involved in immune response (GO:0002283) | 2.96396248 |
| 71 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.95673889 |
| 72 | interferon-gamma production (GO:0032609) | 2.93681138 |
| 73 | dendritic cell differentiation (GO:0097028) | 2.93374988 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 2.91532016 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.91348082 |
| 76 | positive regulation of T-helper cell differentiation (GO:0045624) | 2.90528360 |
| 77 | regulation of immunoglobulin secretion (GO:0051023) | 2.90057426 |
| 78 | T cell migration (GO:0072678) | 2.89683504 |
| 79 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.88860783 |
| 80 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.88273179 |
| 81 | leukocyte aggregation (GO:0070486) | 2.88153588 |
| 82 | cellular extravasation (GO:0045123) | 2.88083615 |
| 83 | positive regulation of type 2 immune response (GO:0002830) | 2.87852857 |
| 84 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.86857882 |
| 85 | response to interferon-beta (GO:0035456) | 2.85994121 |
| 86 | thymic T cell selection (GO:0045061) | 2.85508581 |
| 87 | regulation of interleukin-12 production (GO:0032655) | 2.84886435 |
| 88 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.84746696 |
| 89 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84297103 |
| 90 | regulation of T cell tolerance induction (GO:0002664) | 2.83841695 |
| 91 | T-helper 1 type immune response (GO:0042088) | 2.83353149 |
| 92 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.82521424 |
| 93 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82454309 |
| 94 | * positive regulation of B cell differentiation (GO:0045579) | 2.81520619 |
| 95 | positive regulation of T cell cytokine production (GO:0002726) | 2.80939243 |
| 96 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.79874939 |
| 97 | regulation of mast cell degranulation (GO:0043304) | 2.79616460 |
| 98 | response to peptidoglycan (GO:0032494) | 2.77867718 |
| 99 | T cell selection (GO:0045058) | 2.77515441 |
| 100 | response to interferon-alpha (GO:0035455) | 2.76592435 |
| 101 | positive regulation of DNA recombination (GO:0045911) | 2.76527707 |
| 102 | regulation of response to interferon-gamma (GO:0060330) | 2.76023166 |
| 103 | positive regulation of macrophage differentiation (GO:0045651) | 2.75722909 |
| 104 | regulation of hypersensitivity (GO:0002883) | 2.73626469 |
| 105 | ribosomal small subunit assembly (GO:0000028) | 2.73438024 |
| 106 | negative regulation of interleukin-12 production (GO:0032695) | 2.73259760 |
| 107 | mature B cell differentiation involved in immune response (GO:0002313) | 2.72381243 |
| 108 | regulation of T-helper 1 type immune response (GO:0002825) | 2.72332084 |
| 109 | negative regulation of innate immune response (GO:0045824) | 2.71948479 |
| 110 | detection of molecule of bacterial origin (GO:0032490) | 2.71629936 |
| 111 | response to host (GO:0075136) | 2.71145157 |
| 112 | response to host defenses (GO:0052200) | 2.71145157 |
| 113 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.71145157 |
| 114 | tolerance induction (GO:0002507) | 2.70884746 |
| 115 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.70871327 |
| 116 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.70563022 |
| 117 | * regulation of B cell differentiation (GO:0045577) | 2.70139232 |
| 118 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.70102090 |
| 119 | regulation of necroptotic process (GO:0060544) | 2.69875506 |
| 120 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.68554752 |
| 121 | regulation of tolerance induction (GO:0002643) | 2.67764846 |
| 122 | mature B cell differentiation (GO:0002335) | 2.66968145 |
| 123 | cellular response to interferon-gamma (GO:0071346) | 2.66789633 |
| 124 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.66672985 |
| 125 | regulation of vitamin metabolic process (GO:0030656) | 2.66563535 |
| 126 | * regulation of natural killer cell differentiation (GO:0032823) | 2.65088427 |
| 127 | cellular response to interferon-beta (GO:0035458) | 2.64694675 |
| 128 | regulation of chronic inflammatory response (GO:0002676) | 2.64667603 |
| 129 | cellular response to zinc ion (GO:0071294) | 2.64381521 |
| 130 | growth hormone receptor signaling pathway (GO:0060396) | 2.64057665 |
| 131 | * positive regulation of activated T cell proliferation (GO:0042104) | 2.63859655 |
| 132 | * positive regulation of cytokine biosynthetic process (GO:0042108) | 2.63565319 |
| 133 | regulation of regulatory T cell differentiation (GO:0045589) | 2.63151992 |
| 134 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.62766310 |
| 135 | lymph node development (GO:0048535) | 2.60047285 |
| 136 | regulation of antigen processing and presentation (GO:0002577) | 2.58646709 |
| 137 | * regulation of interleukin-2 production (GO:0032663) | 2.57908589 |
| 138 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.57401073 |
| 139 | T-helper cell differentiation (GO:0042093) | 2.57401073 |
| 140 | germinal center formation (GO:0002467) | 2.56819218 |
| 141 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56630290 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.20097769 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.24501351 |
| 3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.93560223 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.85160993 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.82923686 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.67092814 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.51125941 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.43670775 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.15571767 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13076939 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78703310 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.71508462 |
| 13 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.71027522 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.64710206 |
| 15 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.62976514 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.61871298 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.56081184 |
| 18 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52751931 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50940031 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.47037849 |
| 21 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45639932 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.37586752 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.34738979 |
| 24 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.32857858 |
| 25 | MAF_26560356_Chip-Seq_TH1_Human | 2.25935069 |
| 26 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16811473 |
| 27 | MYB_26560356_Chip-Seq_TH1_Human | 2.13880446 |
| 28 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.10528002 |
| 29 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07698547 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07274922 |
| 31 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02004250 |
| 32 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01137196 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.93792004 |
| 34 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.91877581 |
| 35 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.84714183 |
| 36 | GATA1_19941826_ChIP-Seq_K562_Human | 1.83014271 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80014492 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.75146094 |
| 39 | UTX_26944678_Chip-Seq_JUKART_Human | 1.73829620 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.72507456 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71696283 |
| 42 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68027019 |
| 43 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.67616114 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67247437 |
| 45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66462149 |
| 46 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64011545 |
| 47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.54749153 |
| 48 | * MAF_26560356_Chip-Seq_TH2_Human | 1.43864858 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42133761 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41848354 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40017492 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37347221 |
| 53 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37129232 |
| 54 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35906196 |
| 55 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31970664 |
| 56 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.31850275 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31390493 |
| 58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31293139 |
| 59 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29216914 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.28566477 |
| 61 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27759318 |
| 62 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.27181107 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25477388 |
| 64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24900795 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24133420 |
| 66 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21467974 |
| 67 | GATA2_19941826_ChIP-Seq_K562_Human | 1.19427146 |
| 68 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.16564409 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14030601 |
| 70 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13204329 |
| 71 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13152912 |
| 72 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12520980 |
| 73 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.12456638 |
| 74 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12207504 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11914627 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09734266 |
| 77 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08007633 |
| 78 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06254464 |
| 79 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06040116 |
| 80 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05047298 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04621304 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.04338498 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03114584 |
| 84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02402322 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98509171 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.97335604 |
| 87 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96900511 |
| 88 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96097573 |
| 89 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.94910143 |
| 90 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94361835 |
| 91 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93713822 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92309086 |
| 93 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.92236594 |
| 94 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91759179 |
| 95 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91747497 |
| 96 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.89689552 |
| 97 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86982363 |
| 98 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86389314 |
| 99 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.83486253 |
| 100 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.83257090 |
| 101 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.83248949 |
| 102 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83198978 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83136362 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.80507035 |
| 105 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79838809 |
| 106 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79677935 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78904339 |
| 108 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78799474 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78392287 |
| 110 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.78005712 |
| 111 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.77660850 |
| 112 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75827389 |
| 113 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75438588 |
| 114 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.74734082 |
| 115 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.74590282 |
| 116 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.74536001 |
| 117 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.74394803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.01935756 |
| 2 | MP0000685_abnormal_immune_system | 3.66489055 |
| 3 | MP0009785_altered_susceptibility_to | 3.12537155 |
| 4 | MP0003436_decreased_susceptibility_to | 3.05853842 |
| 5 | MP0005671_abnormal_response_to | 3.04693233 |
| 6 | MP0001790_abnormal_immune_system | 2.86933001 |
| 7 | MP0005387_immune_system_phenotype | 2.86933001 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.71525682 |
| 9 | MP0003763_abnormal_thymus_physiology | 2.71009769 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.70001944 |
| 11 | MP0001800_abnormal_humoral_immune | 2.65473197 |
| 12 | MP0002148_abnormal_hypersensitivity_rea | 2.65193413 |
| 13 | MP0005025_abnormal_response_to | 2.54315094 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.42897059 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.40649919 |
| 16 | MP0002006_tumorigenesis | 2.40091490 |
| 17 | MP0003300_gastrointestinal_ulcer | 2.38247605 |
| 18 | * MP0002723_abnormal_immune_serum | 2.37824359 |
| 19 | MP0001853_heart_inflammation | 2.35773090 |
| 20 | MP0003724_increased_susceptibility_to | 2.29821613 |
| 21 | MP0005451_abnormal_body_composition | 2.27680388 |
| 22 | MP0010155_abnormal_intestine_physiology | 2.23752186 |
| 23 | * MP0001819_abnormal_immune_cell | 2.21044149 |
| 24 | MP0002254_reproductive_system_inflammat | 2.20580296 |
| 25 | * MP0002420_abnormal_adaptive_immunity | 2.19843288 |
| 26 | MP0003303_peritoneal_inflammation | 2.17049952 |
| 27 | * MP0002419_abnormal_innate_immunity | 2.16572101 |
| 28 | MP0004510_myositis | 2.15653927 |
| 29 | MP0002405_respiratory_system_inflammati | 2.12497491 |
| 30 | MP0001873_stomach_inflammation | 2.11909950 |
| 31 | * MP0002398_abnormal_bone_marrow | 2.11172100 |
| 32 | MP0006082_CNS_inflammation | 2.04833882 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.97867698 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.94320994 |
| 35 | MP0001545_abnormal_hematopoietic_system | 1.94320994 |
| 36 | MP0005310_abnormal_salivary_gland | 1.93407708 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.89878003 |
| 38 | * MP0000716_abnormal_immune_system | 1.88335580 |
| 39 | MP0004947_skin_inflammation | 1.82305654 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.80317135 |
| 41 | * MP0001845_abnormal_inflammatory_respons | 1.75173364 |
| 42 | MP0003172_abnormal_lysosome_physiology | 1.74617854 |
| 43 | * MP0002722_abnormal_immune_system | 1.68297413 |
| 44 | * MP0000689_abnormal_spleen_morphology | 1.68218401 |
| 45 | MP0003866_abnormal_defecation | 1.63389168 |
| 46 | * MP0002429_abnormal_blood_cell | 1.60918665 |
| 47 | MP0009278_abnormal_bone_marrow | 1.59228278 |
| 48 | MP0009764_decreased_sensitivity_to | 1.50114717 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.47167997 |
| 50 | MP0010352_gastrointestinal_tract_polyps | 1.47003462 |
| 51 | * MP0000703_abnormal_thymus_morphology | 1.46972482 |
| 52 | MP0003075_altered_response_to | 1.44337978 |
| 53 | MP0002138_abnormal_hepatobiliary_system | 1.36445629 |
| 54 | * MP0008469_abnormal_protein_level | 1.35089498 |
| 55 | MP0003806_abnormal_nucleotide_metabolis | 1.30657938 |
| 56 | MP0000490_abnormal_crypts_of | 1.26096158 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.23355439 |
| 58 | MP0008004_abnormal_stomach_pH | 1.23240063 |
| 59 | MP0000858_altered_metastatic_potential | 1.22010440 |
| 60 | MP0002933_joint_inflammation | 1.19777822 |
| 61 | MP0003448_altered_tumor_morphology | 1.17051494 |
| 62 | MP0001348_abnormal_lacrimal_gland | 1.13842464 |
| 63 | MP0000604_amyloidosis | 1.11364341 |
| 64 | MP0008057_abnormal_DNA_replication | 1.03911174 |
| 65 | MP0008260_abnormal_autophagy | 1.03789886 |
| 66 | MP0002139_abnormal_hepatobiliary_system | 1.00821410 |
| 67 | MP0005666_abnormal_adipose_tissue | 0.99103174 |
| 68 | * MP0001881_abnormal_mammary_gland | 0.95228358 |
| 69 | MP0005076_abnormal_cell_differentiation | 0.94162950 |
| 70 | MP0005174_abnormal_tail_pigmentation | 0.93937988 |
| 71 | MP0000343_altered_response_to | 0.93637442 |
| 72 | MP0010307_abnormal_tumor_latency | 0.92924389 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.92181007 |
| 74 | * MP0002019_abnormal_tumor_incidence | 0.91724768 |
| 75 | MP0003690_abnormal_glial_cell | 0.90225816 |
| 76 | MP0002877_abnormal_melanocyte_morpholog | 0.88914902 |
| 77 | MP0002132_abnormal_respiratory_system | 0.86305392 |
| 78 | MP0009763_increased_sensitivity_to | 0.85427831 |
| 79 | MP0002332_abnormal_exercise_endurance | 0.83644876 |
| 80 | MP0009765_abnormal_xenobiotic_induced | 0.79463983 |
| 81 | MP0005164_abnormal_response_to | 0.77113299 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.76857989 |
| 83 | MP0003566_abnormal_cell_adhesion | 0.75366896 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 0.74264933 |
| 85 | MP0002163_abnormal_gland_morphology | 0.73366190 |
| 86 | MP0004883_abnormal_blood_vessel | 0.72236045 |
| 87 | MP0002009_preneoplasia | 0.71333964 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.70893203 |
| 89 | MP0003828_pulmonary_edema | 0.70761840 |
| 90 | MP0001663_abnormal_digestive_system | 0.70582574 |
| 91 | MP0000371_diluted_coat_color | 0.70522576 |
| 92 | MP0003186_abnormal_redox_activity | 0.70489043 |
| 93 | MP0005023_abnormal_wound_healing | 0.70262265 |
| 94 | * MP0000609_abnormal_liver_physiology | 0.70115531 |
| 95 | MP0003453_abnormal_keratinocyte_physiol | 0.68667690 |
| 96 | MP0004381_abnormal_hair_follicle | 0.67953150 |
| 97 | MP0001851_eye_inflammation | 0.66086534 |
| 98 | * MP0005535_abnormal_body_temperature | 0.65797033 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.65744605 |
| 100 | MP0005058_abnormal_lysosome_morphology | 0.64169704 |
| 101 | MP0005390_skeleton_phenotype | 0.62982573 |
| 102 | MP0000249_abnormal_blood_vessel | 0.62646493 |
| 103 | MP0006054_spinal_hemorrhage | 0.61260374 |
| 104 | MP0005165_increased_susceptibility_to | 0.60779317 |
| 105 | MP0008874_decreased_physiological_sensi | 0.59409226 |
| 106 | MP0009115_abnormal_fat_cell | 0.59226643 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.58677031 |
| 108 | MP0005166_decreased_susceptibility_to | 0.58566334 |
| 109 | MP0003693_abnormal_embryo_hatching | 0.57950545 |
| 110 | * MP0000627_abnormal_mammary_gland | 0.57486872 |
| 111 | MP0003795_abnormal_bone_structure | 0.56878935 |
| 112 | MP0003191_abnormal_cellular_cholesterol | 0.56490698 |
| 113 | MP0003221_abnormal_cardiomyocyte_apopto | 0.56305530 |
| 114 | MP0000598_abnormal_liver_morphology | 0.55439160 |
| 115 | MP0009840_abnormal_foam_cell | 0.53617169 |
| 116 | MP0004130_abnormal_muscle_cell | 0.53562613 |
| 117 | MP0004782_abnormal_surfactant_physiolog | 0.53185365 |
| 118 | MP0003091_abnormal_cell_migration | 0.52907407 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.52062514 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.51606452 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.51531209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.98811032 |
| 2 | Recurrent fungal infections (HP:0002841) | 4.70856626 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.66210864 |
| 4 | Myositis (HP:0100614) | 4.49040358 |
| 5 | Recurrent viral infections (HP:0004429) | 4.44282067 |
| 6 | Chronic otitis media (HP:0000389) | 4.36584333 |
| 7 | Thrombocytosis (HP:0001894) | 4.27103478 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.04007654 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.84350965 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.84350965 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.83394203 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82358637 |
| 13 | Optic neuritis (HP:0100653) | 3.77223879 |
| 14 | Retrobulbar optic neuritis (HP:0100654) | 3.77223879 |
| 15 | Orchitis (HP:0100796) | 3.75486701 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72818341 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72818341 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72818341 |
| 19 | Mediastinal lymphadenopathy (HP:0100721) | 3.64080619 |
| 20 | Abnormality of T cell number (HP:0011839) | 3.56721712 |
| 21 | Nasal polyposis (HP:0100582) | 3.55103833 |
| 22 | Panhypogammaglobulinemia (HP:0003139) | 3.53839168 |
| 23 | T lymphocytopenia (HP:0005403) | 3.44845250 |
| 24 | IgM deficiency (HP:0002850) | 3.39424208 |
| 25 | Vasculitis (HP:0002633) | 3.39038460 |
| 26 | Stomatitis (HP:0010280) | 3.33925403 |
| 27 | Recurrent skin infections (HP:0001581) | 3.30993757 |
| 28 | Abnormality of T cells (HP:0002843) | 3.30703256 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.30009931 |
| 30 | Recurrent bronchitis (HP:0002837) | 3.28739065 |
| 31 | Arterial thrombosis (HP:0004420) | 3.20122639 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.19933209 |
| 33 | Abnormality of the nasal mucosa (HP:0000433) | 3.18933382 |
| 34 | Petechiae (HP:0000967) | 3.18875981 |
| 35 | IgA deficiency (HP:0002720) | 3.15952775 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 3.11048609 |
| 37 | Interstitial pulmonary disease (HP:0006530) | 3.09506153 |
| 38 | Pulmonary infiltrates (HP:0002113) | 2.95667951 |
| 39 | Abnormality of macrophages (HP:0004311) | 2.95511465 |
| 40 | Cellulitis (HP:0100658) | 2.94961678 |
| 41 | Increased IgM level (HP:0003496) | 2.94828678 |
| 42 | Pustule (HP:0200039) | 2.92230062 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.89865757 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.87748790 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.87308959 |
| 46 | Gastrointestinal inflammation (HP:0004386) | 2.87058249 |
| 47 | Hypertensive crisis (HP:0100735) | 2.82180983 |
| 48 | Meningitis (HP:0001287) | 2.81884587 |
| 49 | Gingival bleeding (HP:0000225) | 2.76120403 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.76073556 |
| 51 | Hemoptysis (HP:0002105) | 2.76015551 |
| 52 | Loss of speech (HP:0002371) | 2.75875570 |
| 53 | Chronic diarrhea (HP:0002028) | 2.73159124 |
| 54 | Dysostosis multiplex (HP:0000943) | 2.72923740 |
| 55 | Periodontitis (HP:0000704) | 2.72898020 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.72243882 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.69757466 |
| 58 | Leukocytosis (HP:0001974) | 2.65693924 |
| 59 | Increased IgE level (HP:0003212) | 2.63804216 |
| 60 | Colitis (HP:0002583) | 2.63654799 |
| 61 | Eosinophilia (HP:0001880) | 2.62683338 |
| 62 | Epistaxis (HP:0000421) | 2.60536550 |
| 63 | Hypergammaglobulinemia (HP:0010702) | 2.60397237 |
| 64 | Prolonged bleeding time (HP:0003010) | 2.60377234 |
| 65 | Keratoconjunctivitis sicca (HP:0001097) | 2.60299626 |
| 66 | IgG deficiency (HP:0004315) | 2.58279029 |
| 67 | Purpura (HP:0000979) | 2.56242534 |
| 68 | Chest pain (HP:0100749) | 2.52555234 |
| 69 | Amaurosis fugax (HP:0100576) | 2.50828117 |
| 70 | Granulocytopenia (HP:0001913) | 2.50076454 |
| 71 | Polycythemia (HP:0001901) | 2.49780863 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.49513481 |
| 73 | Gingivitis (HP:0000230) | 2.45183845 |
| 74 | Hepatosplenomegaly (HP:0001433) | 2.40200727 |
| 75 | Agammaglobulinemia (HP:0004432) | 2.39654419 |
| 76 | Abnormality of iron homeostasis (HP:0011031) | 2.38652485 |
| 77 | Fatigue (HP:0012378) | 2.38450998 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.37004455 |
| 79 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.32703091 |
| 80 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.32657274 |
| 81 | Gangrene (HP:0100758) | 2.32643221 |
| 82 | Spontaneous hematomas (HP:0007420) | 2.31791951 |
| 83 | Lymphopenia (HP:0001888) | 2.31006433 |
| 84 | Abnormality of eosinophils (HP:0001879) | 2.30096523 |
| 85 | Joint swelling (HP:0001386) | 2.26669050 |
| 86 | Encephalitis (HP:0002383) | 2.26464336 |
| 87 | Obstructive lung disease (HP:0006536) | 2.24197055 |
| 88 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24197055 |
| 89 | Autoimmune hemolytic anemia (HP:0001890) | 2.23983689 |
| 90 | Pulmonary embolism (HP:0002204) | 2.23548674 |
| 91 | Severe combined immunodeficiency (HP:0004430) | 2.21440943 |
| 92 | Impaired platelet aggregation (HP:0003540) | 2.20246393 |
| 93 | Abnormal platelet function (HP:0011869) | 2.20246393 |
| 94 | Emphysema (HP:0002097) | 2.18494404 |
| 95 | B lymphocytopenia (HP:0010976) | 2.17062306 |
| 96 | Abnormality of B cell number (HP:0010975) | 2.17062306 |
| 97 | Basal ganglia calcification (HP:0002135) | 2.16822235 |
| 98 | Abnormal gallbladder physiology (HP:0012438) | 2.15684462 |
| 99 | Cholecystitis (HP:0001082) | 2.15684462 |
| 100 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.15604400 |
| 101 | Disinhibition (HP:0000734) | 2.13420131 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 2.13297901 |
| 103 | Combined immunodeficiency (HP:0005387) | 2.13230894 |
| 104 | Slow saccadic eye movements (HP:0000514) | 2.12794924 |
| 105 | Anorexia (HP:0002039) | 2.11535353 |
| 106 | Myocardial infarction (HP:0001658) | 2.09608712 |
| 107 | Thyroiditis (HP:0100646) | 2.09469353 |
| 108 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.09350881 |
| 109 | Abnormality of the pleura (HP:0002103) | 2.08646322 |
| 110 | Skin ulcer (HP:0200042) | 2.07580846 |
| 111 | Acne (HP:0001061) | 2.07478405 |
| 112 | Polyneuropathy (HP:0001271) | 2.06792826 |
| 113 | Lymphoma (HP:0002665) | 2.01520572 |
| 114 | Aplastic anemia (HP:0001915) | 2.01122606 |
| 115 | Chronic sinusitis (HP:0011109) | 2.01045718 |
| 116 | Increased serum ferritin (HP:0003281) | 1.99475414 |
| 117 | Osteomyelitis (HP:0002754) | 1.98139820 |
| 118 | Abnormal platelet volume (HP:0011876) | 1.96439996 |
| 119 | Hypoplasia of the thymus (HP:0000778) | 1.96053369 |
| 120 | Episodic fever (HP:0001954) | 1.95046225 |
| 121 | Vertigo (HP:0002321) | 1.94986645 |
| 122 | Glomerulopathy (HP:0100820) | 1.94907678 |
| 123 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94115816 |
| 124 | Albinism (HP:0001022) | 1.93140710 |
| 125 | Splenomegaly (HP:0001744) | 1.92600786 |
| 126 | Abnormal number of erythroid precursors (HP:0012131) | 1.89935705 |
| 127 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89690405 |
| 128 | Urticaria (HP:0001025) | 1.89635515 |
| 129 | Osteolytic defects of the hand bones (HP:0009699) | 1.88643321 |
| 130 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.88643321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.10713092 |
| 2 | MAP3K14 | 3.75394497 |
| 3 | PRPF4B | 3.24481564 |
| 4 | * JAK3 | 3.08487945 |
| 5 | TXK | 2.89740760 |
| 6 | TYK2 | 2.86619597 |
| 7 | EEF2K | 2.78868416 |
| 8 | TBK1 | 2.77307099 |
| 9 | IKBKE | 2.56467096 |
| 10 | NME2 | 2.49887134 |
| 11 | IKBKB | 2.40201589 |
| 12 | ZAP70 | 2.25886090 |
| 13 | TAOK2 | 2.02592836 |
| 14 | KIT | 2.02528877 |
| 15 | CHUK | 1.95800236 |
| 16 | IRAK4 | 1.93146036 |
| 17 | JAK1 | 1.89172451 |
| 18 | ERN1 | 1.84325509 |
| 19 | FGFR4 | 1.82305167 |
| 20 | IRAK3 | 1.78849371 |
| 21 | TRIB3 | 1.76716670 |
| 22 | PIM2 | 1.69871241 |
| 23 | EPHB1 | 1.66933468 |
| 24 | TAOK3 | 1.66907764 |
| 25 | BMPR2 | 1.66481436 |
| 26 | BLK | 1.57785997 |
| 27 | TEC | 1.54897402 |
| 28 | EPHA3 | 1.51436843 |
| 29 | STK10 | 1.46415746 |
| 30 | NLK | 1.45197882 |
| 31 | PIM1 | 1.41766331 |
| 32 | * BTK | 1.41557102 |
| 33 | MAP2K3 | 1.41375498 |
| 34 | SIK1 | 1.39252903 |
| 35 | FGFR3 | 1.35743126 |
| 36 | * SYK | 1.34329176 |
| 37 | MAP3K10 | 1.32639592 |
| 38 | MAP3K13 | 1.32538834 |
| 39 | GRK7 | 1.28906512 |
| 40 | CSF1R | 1.27064655 |
| 41 | MST4 | 1.26233264 |
| 42 | RIPK4 | 1.24052405 |
| 43 | * LCK | 1.21555841 |
| 44 | LRRK2 | 1.21154005 |
| 45 | HCK | 1.19604545 |
| 46 | RPS6KA4 | 1.15154143 |
| 47 | FLT3 | 1.13718687 |
| 48 | ITK | 1.13608631 |
| 49 | PKN2 | 1.12706202 |
| 50 | FGR | 1.07247565 |
| 51 | RIPK1 | 1.04332608 |
| 52 | MAP3K11 | 0.99083965 |
| 53 | CSK | 0.98784760 |
| 54 | TGFBR1 | 0.97247909 |
| 55 | * JAK2 | 0.96858223 |
| 56 | PTK6 | 0.95051880 |
| 57 | SMG1 | 0.94492703 |
| 58 | KSR2 | 0.93359839 |
| 59 | ICK | 0.89445114 |
| 60 | SIK2 | 0.88360225 |
| 61 | TRPM7 | 0.83123020 |
| 62 | CDC42BPA | 0.81735246 |
| 63 | TGFBR2 | 0.81200678 |
| 64 | MOS | 0.79986323 |
| 65 | RPS6KB2 | 0.79373037 |
| 66 | MST1R | 0.73187918 |
| 67 | CDK4 | 0.71623357 |
| 68 | MAP3K3 | 0.71579577 |
| 69 | CDK12 | 0.71228112 |
| 70 | * LYN | 0.70802656 |
| 71 | TTN | 0.68460731 |
| 72 | MAP3K7 | 0.68215920 |
| 73 | MAPK11 | 0.67500345 |
| 74 | STK4 | 0.66518410 |
| 75 | MAP3K8 | 0.66475699 |
| 76 | MAPK12 | 0.66461093 |
| 77 | IRAK2 | 0.65849979 |
| 78 | MAP2K6 | 0.65591434 |
| 79 | NEK9 | 0.64186445 |
| 80 | MARK3 | 0.63984911 |
| 81 | TESK2 | 0.62558729 |
| 82 | MAPKAPK2 | 0.62462478 |
| 83 | DDR2 | 0.61640941 |
| 84 | SCYL2 | 0.61135287 |
| 85 | MAP3K5 | 0.60956443 |
| 86 | GRK6 | 0.58830793 |
| 87 | IRAK1 | 0.58086664 |
| 88 | SIK3 | 0.54632235 |
| 89 | MARK2 | 0.54356553 |
| 90 | PDPK1 | 0.52389720 |
| 91 | RAF1 | 0.52376744 |
| 92 | RPS6KA6 | 0.52352390 |
| 93 | MAP3K6 | 0.51084881 |
| 94 | PRKCQ | 0.50391347 |
| 95 | HIPK2 | 0.50211564 |
| 96 | CDK6 | 0.49527094 |
| 97 | BMX | 0.48981688 |
| 98 | RPS6KA1 | 0.48315565 |
| 99 | TAOK1 | 0.48271658 |
| 100 | MATK | 0.46629235 |
| 101 | PDK1 | 0.46011019 |
| 102 | CAMK1D | 0.45630961 |
| 103 | KDR | 0.45382908 |
| 104 | MAPKAPK3 | 0.45126192 |
| 105 | CLK1 | 0.44327334 |
| 106 | TNK2 | 0.44214285 |
| 107 | MAPK7 | 0.43440284 |
| 108 | ABL1 | 0.41167218 |
| 109 | RET | 0.40151641 |
| 110 | STK3 | 0.39681460 |
| 111 | NUAK1 | 0.38157572 |
| 112 | EIF2AK2 | 0.37811469 |
| 113 | MAP3K1 | 0.36895000 |
| 114 | EGFR | 0.36767599 |
| 115 | RPS6KB1 | 0.36164367 |
| 116 | PIK3CG | 0.35703609 |
| 117 | MAPK4 | 0.35591969 |
| 118 | RPS6KC1 | 0.35464120 |
| 119 | RPS6KL1 | 0.35464120 |
| 120 | RPS6KA5 | 0.35051881 |
| 121 | FES | 0.34208577 |
| 122 | CAMKK1 | 0.33890450 |
| 123 | FYN | 0.32772875 |
| 124 | * MAPK3 | 0.32096140 |
| 125 | ALK | 0.31355611 |
| 126 | PASK | 0.30039759 |
| 127 | TSSK6 | 0.28042706 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 3.08842766 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 3.04425071 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01028478 |
| 4 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.87953336 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74622837 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.67623691 |
| 7 | * Measles_Homo sapiens_hsa05162 | 2.55774111 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.52822152 |
| 9 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.42015324 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.30954412 |
| 11 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.21188883 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.09332278 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.04515309 |
| 14 | Legionellosis_Homo sapiens_hsa05134 | 2.01896074 |
| 15 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98452228 |
| 16 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.90152417 |
| 17 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.87949302 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.86289259 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.83626122 |
| 20 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.82581317 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.82068647 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.79182392 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.75850202 |
| 24 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.71864047 |
| 25 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69404568 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.67020869 |
| 27 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46907260 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.44471115 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.44442586 |
| 30 | * Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.42161706 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40081454 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.37008553 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.35045766 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.29698253 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27452066 |
| 36 | * Hepatitis B_Homo sapiens_hsa05161 | 1.27115072 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.25750229 |
| 38 | Shigellosis_Homo sapiens_hsa05131 | 1.18413870 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15051638 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05340062 |
| 41 | * Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.04341195 |
| 42 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04146411 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04066349 |
| 44 | Hepatitis C_Homo sapiens_hsa05160 | 1.02216045 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.01546350 |
| 46 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.00341209 |
| 47 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98629052 |
| 48 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98218381 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.98086076 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.95858052 |
| 51 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92979482 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.92710001 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90288619 |
| 54 | DNA replication_Homo sapiens_hsa03030 | 0.89359079 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88260089 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.83695286 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80735914 |
| 58 | * Viral carcinogenesis_Homo sapiens_hsa05203 | 0.79494995 |
| 59 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.79344418 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70583284 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 0.68658605 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.68624432 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.67152486 |
| 64 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65365947 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64688259 |
| 66 | Insulin resistance_Homo sapiens_hsa04931 | 0.63259627 |
| 67 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62868431 |
| 68 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61673034 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61502787 |
| 70 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59974771 |
| 71 | Base excision repair_Homo sapiens_hsa03410 | 0.59197756 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.57828762 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.57620651 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.56787302 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55594199 |
| 76 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52714448 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52255188 |
| 78 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50954133 |
| 79 | Bladder cancer_Homo sapiens_hsa05219 | 0.50889432 |
| 80 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49667642 |
| 81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48014183 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47843541 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44581523 |
| 84 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44228695 |
| 85 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43290481 |
| 86 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38908679 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38446701 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36175649 |
| 89 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35361699 |
| 90 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.34894143 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33702153 |
| 92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.32433256 |
| 93 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31776783 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.31535020 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30881353 |
| 96 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.30690692 |
| 97 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30490466 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.28413726 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28135477 |
| 100 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.27246203 |
| 101 | Prostate cancer_Homo sapiens_hsa05215 | 0.24609736 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.24494819 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.24380994 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24352309 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23364325 |
| 106 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.23101385 |
| 107 | Mismatch repair_Homo sapiens_hsa03430 | 0.22779545 |
| 108 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.22077836 |
| 109 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.21897648 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.21414738 |
| 111 | RNA degradation_Homo sapiens_hsa03018 | 0.21085895 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.20545915 |
| 113 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.20382976 |
| 114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20109183 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19773161 |
| 116 | Spliceosome_Homo sapiens_hsa03040 | 0.18573702 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.18194157 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17324923 |
| 119 | Endometrial cancer_Homo sapiens_hsa05213 | 0.17246911 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.17156106 |
| 121 | Homologous recombination_Homo sapiens_hsa03440 | 0.17142230 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16526091 |
| 123 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.15824816 |
| 124 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.15751112 |
| 125 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15587440 |

